BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 11329012)

  • 61. Identification of inactivating mutations in the JAK1, SYNJ2, and CLPTM1 genes in prostate cancer cells using inhibition of nonsense-mediated decay and microarray analysis.
    Rossi MR; Hawthorn L; Platt J; Burkhardt T; Cowell JK; Ionov Y
    Cancer Genet Cytogenet; 2005 Sep; 161(2):97-103. PubMed ID: 16102578
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Control of gene expression through the nonsense-mediated RNA decay pathway.
    Nickless A; Bailis JM; You Z
    Cell Biosci; 2017; 7():26. PubMed ID: 28533900
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Molecular cloning of novel transcripts of the adaptor-related protein complex 2 alpha 1 subunit (AP2A1) gene, using Next-Generation Sequencing.
    Adamopoulos PG; Kontos CK; Diamantopoulos MA; Scorilas A
    Gene; 2018 Dec; 678():55-64. PubMed ID: 30081190
    [TBL] [Abstract][Full Text] [Related]  

  • 64. NMD inhibition fails to identify tumour suppressor genes in microsatellite stable gastric cancer cell lines.
    Buffart TE; Tijssen M; El-Bchiri J; Duval A; van de Wiel MA; Ylstra B; Meijer GA; Carvalho B
    BMC Med Genomics; 2009 Jun; 2():39. PubMed ID: 19563644
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Distribution and effects of nonsense polymorphisms in human genes.
    Yamaguchi-Kabata Y; Shimada MK; Hayakawa Y; Minoshima S; Chakraborty R; Gojobori T; Imanishi T
    PLoS One; 2008; 3(10):e3393. PubMed ID: 18852891
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A second, large deletion in the HEXB gene in a patient with infantile Sandhoff disease.
    Zhang ZX; Wakamatsu N; Akerman BR; Mules EH; Thomas GH; Gravel RA
    Hum Mol Genet; 1995 Apr; 4(4):777-80. PubMed ID: 7633435
    [No Abstract]   [Full Text] [Related]  

  • 67. The antimalarial drug mefloquine enhances TP53 premature termination codon readthrough by aminoglycoside G418.
    Ferguson MW; Gerak CAN; Chow CCT; Rastelli EJ; Elmore KE; Stahl F; Hosseini-Farahabadi S; Baradaran-Heravi A; Coltart DM; Roberge M
    PLoS One; 2019; 14(5):e0216423. PubMed ID: 31120902
    [TBL] [Abstract][Full Text] [Related]  

  • 68. NMD microarray analysis for rapid genome-wide screen of mutated genes in cancer.
    Wolf M; Edgren H; Muggerud A; Kilpinen S; Huusko P; Sørlie T; Mousses S; Kallioniemi O
    Cell Oncol; 2005; 27(3):169-73. PubMed ID: 16037637
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Sequence and copy number analyses of HEXB gene in patients affected by Sandhoff disease: functional characterization of 9 novel sequence variants.
    Zampieri S; Cattarossi S; Oller Ramirez AM; Rosano C; Lourenco CM; Passon N; Moroni I; Uziel G; Pettinari A; Stanzial F; de Kremer RD; Azar NB; Hazan F; Filocamo M; Bembi B; Dardis A
    PLoS One; 2012; 7(7):e41516. PubMed ID: 22848519
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Inactivation of RB1 in mantle-cell lymphoma detected by nonsense-mediated mRNA decay pathway inhibition and microarray analysis.
    Pinyol M; Bea S; Plà L; Ribrag V; Bosq J; Rosenwald A; Campo E; Jares P
    Blood; 2007 Jun; 109(12):5422-9. PubMed ID: 17332242
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Enhanced production of functional proteins from defective genes.
    Xi B; Guan F; Lawrence DS
    J Am Chem Soc; 2004 May; 126(18):5660-1. PubMed ID: 15125646
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Targeting Nonsense Mutations in Diseases with Translational Read-Through-Inducing Drugs (TRIDs).
    Nagel-Wolfrum K; Möller F; Penner I; Baasov T; Wolfrum U
    BioDrugs; 2016 Apr; 30(2):49-74. PubMed ID: 26886021
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Mutation analysis of a Sandhoff disease patient in the Maronite community in Cyprus.
    Hara Y; Ioannou P; Drousiotou A; Stylianidou G; Anastasiadou V; Suzuki K
    Hum Genet; 1994 Aug; 94(2):136-40. PubMed ID: 8045559
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A meta-analysis of nonsense mutations causing human genetic disease.
    Mort M; Ivanov D; Cooper DN; Chuzhanova NA
    Hum Mutat; 2008 Aug; 29(8):1037-47. PubMed ID: 18454449
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The cycle of nonsense.
    Wilkinson MF
    Mol Cell; 2003 Nov; 12(5):1059-61. PubMed ID: 14636563
    [No Abstract]   [Full Text] [Related]  

  • 76. aenmd: Annotating escape from nonsense-mediated decay for transcripts with protein-truncating variants.
    Klonowski J; Liang Q; Coban-Akdemir Z; Lo C; Kostka D
    bioRxiv; 2023 Mar; ():. PubMed ID: 36993377
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Human SNPs resulting in premature stop codons and protein truncation.
    Savas S; Tuzmen S; Ozcelik H
    Hum Genomics; 2006 Mar; 2(5):274-86. PubMed ID: 16595072
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The diagnosis of inherited metabolic diseases by microarray gene expression profiling.
    Hernandez MA; Schulz R; Chaplin T; Young BD; Perrett D; Champion MP; Taanman JW; Fensom A; Marinaki AM
    Orphanet J Rare Dis; 2010 Dec; 5():34. PubMed ID: 21122112
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A rule for termination-codon position within intron-containing genes: when nonsense affects RNA abundance.
    Nagy E; Maquat LE
    Trends Biochem Sci; 1998 Jun; 23(6):198-9. PubMed ID: 9644970
    [No Abstract]   [Full Text] [Related]  

  • 80. Hidden infidelities of the translational stop signal.
    Tate WP; Poole ES; Mannering SA
    Prog Nucleic Acid Res Mol Biol; 1996; 52():293-335. PubMed ID: 8821264
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.